catalog number :
MBS821044
products full name :
Anti-p15 INK4b Antibody
products short name :
[p15 INK4b]
products name syn :
[MTS2; Cyclin-dependent kinase 4 inhibitor B; Multiple tumor suppressor 2; MTS-2; p14-INK4b; p15-INK4b; p15INK4B]
other names :
[cyclin-dependent kinase 4 inhibitor B isoform 1; Cyclin-dependent kinase 4 inhibitor B; cyclin-dependent kinase 4 inhibitor B; MTS-2; p14-INK4b; p14_INK4B; p15-INK4b; p15_INK4B; CDK4B inhibitor; p14_CDK inhibitor; p15 CDK inhibitor; CDK inhibitory protein; multiple tumor suppressor 2; cyclin-dependent kinases 4 and 6 binding protein; cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4); Multiple tumor suppressor 2; MTS-2; p14-INK4b; p15-INK4b; p15INK4B]
products gene name :
[CDKN2B]
other gene names :
[CDKN2B; CDKN2B; P15; MTS2; TP15; CDK4I; INK4B; p15INK4b; MTS2; MTS-2; p15INK4B]
uniprot entry name :
CDN2B_HUMAN
reactivity :
Human, Mouse, Rat, Monkey, Pig
specificity :
Recognizes endogenous levels of p15 INK4b protein.
purity :
The antibody was purified by immunogen affinity chromatography.
form :
Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
storage stability :
Shipping: Blue ice. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
tested application :
Western Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC)
app notes :
WB (1/500 - 1/1000). IH (1/100 - 1/200). IF/ICC (1/100 - 1/500)
image1 heading :
Western Blot (WB)
image2 heading :
Immunohistochemistry (IHC)
image3 heading :
Immunofluorescence (IF)
other info2 :
Immunogen: KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human p15 INK4b. The exact sequence is proprietary.
products description :
Rabbit polyclonal antibody to p15 INK4b
ncbi acc num :
NP_004927.2
ncbi gb acc num :
NM_004936.3
ncbi pathways :
Cell Cycle Pathway (530733); Cell Cycle, Mitotic Pathway (105765); Cell Cycle Pathway (83054); Cell Cycle Pathway (463); Cellular Senescence Pathway (905991); Cellular Responses To Stress Pathway (645258); Cyclin D Associated Events In G1 Pathway (105767); Disease Pathway (530764); FoxO Signaling Pathway (921162); G1 Phase Pathway (105766)
ncbi summary :
This gene lies adjacent to the tumor suppressor gene CDKN2A in a region that is frequently mutated and deleted in a wide variety of tumors. This gene encodes a cyclin-dependent kinase inhibitor, which forms a complex with CDK4 or CDK6, and prevents the activation of the CDK kinases, thus the encoded protein functions as a cell growth regulator that controls cell cycle G1 progression. The expression of this gene was found to be dramatically induced by TGF beta, which suggested its role in the TGF beta induced growth inhibition. Two alternatively spliced transcript variants of this gene, which encode distinct proteins, have been reported. [provided by RefSeq, Jul 2008]
uniprot summary :
p15-INK4B: a potent inhibitor that nteracts strongly with CDK4 and CDK6. Potential effector of TGF-beta induced cell cycle arrest. Protein type: Inhibitor; Cell cycle regulation; Protein kinase, regulatory subunit; Tumor suppressor. Chromosomal Location of Human Ortholog: 9p21. Cellular Component: nucleoplasm; cytoplasm; cytosol; nucleus. Molecular Function: cyclin-dependent protein kinase inhibitor activity; protein binding; protein kinase binding. Biological Process: spleen development; transcription initiation from RNA polymerase II promoter; transcription, DNA-dependent; megakaryocyte differentiation; mitotic cell cycle checkpoint; positive regulation of transforming growth factor beta receptor signaling pathway; cellular response to nutrient; liver development; response to organic cyclic substance; negative regulation of cell proliferation; response to cytokine stimulus; transforming growth factor beta receptor signaling pathway; cellular response to extracellular stimulus; negative regulation of phosphorylation; positive regulation of epithelial cell differentiation; positive regulation of transcription from RNA polymerase II promoter; gene expression; regulation of cyclin-dependent protein kinase activity; mitotic cell cycle; G2/M transition of mitotic cell cycle; cell cycle arrest; aging; negative regulation of epithelial cell proliferation